Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Reznik

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Presse Medicale (Paris, France : 1983)|June 5, 2016
Therapeutic innovations in endocrine diseases - Part 2: Modified-release glucocorticoid compounds: What good do they provide to the adrenal insufficient patient?Yves Reznik
La Revue Du Praticien|April 2, 2020
[Insulinoma]Julia Morera, Yves Reznik
European Journal of Endocrinology|November 27, 2018
MANAGEMENT OF ENDOCRINE DISEASE: The role of confirmatory tests in the diagnosis of primary aldosteronismJulia Morera, Yves Reznik
Diabetes Care|July 25, 2013
Insulin pump for type 2 diabetes: use and misuse of continuous subcutaneous insulin infusion in type 2 diabetesYves Reznik, Ohad Cohen
La Revue Du Praticien|October 19, 2019
[Hypoglycemia in adults and children]Julia Morera, Yves Reznik
European Endocrinology|April 11, 2018
The OPT2MISE Study - A Review of the Major Findings and Clinical ImplicationsYves Reznik, Michael Joubert
Annales D'Endocrinologie|April 20, 2023
EditorialYves Reznik, Luca Persani,
Diabetes, Obesity & Metabolism|April 12, 2023
Use of insulin pumps and closed-loop systems among people living with diabetes: A narrative review of clinical and cost-effectiveness to enable access to technology and meet the needs of payersJohan Jendle, Yves Reznik
Diabetes Technology & Therapeutics|September 6, 2014
Reductions in A1C with pump therapy in type 2 diabetes are independent of C-peptide and anti-glutamic acid decarboxylase antibody concentrationsYves Reznik, Suiying Huang,
The Lancet. Digital Health|December 18, 2020
Closed-loop insulin delivery: understanding when and how it is effectivePierre-Yves Benhamou, Yves Reznik
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Presse Medicale (Paris, France : 1983)|June 5, 2016
Therapeutic innovations in endocrine diseases - Part 2: Modified-release glucocorticoid compounds: What good do they provide to the adrenal insufficient patient?Yves Reznik
La Revue Du Praticien|April 2, 2020
[Insulinoma]Julia Morera, Yves Reznik
European Journal of Endocrinology|November 27, 2018
MANAGEMENT OF ENDOCRINE DISEASE: The role of confirmatory tests in the diagnosis of primary aldosteronismJulia Morera, Yves Reznik
Diabetes Care|July 25, 2013
Insulin pump for type 2 diabetes: use and misuse of continuous subcutaneous insulin infusion in type 2 diabetesYves Reznik, Ohad Cohen
La Revue Du Praticien|October 19, 2019
[Hypoglycemia in adults and children]Julia Morera, Yves Reznik
European Endocrinology|April 11, 2018
The OPT2MISE Study - A Review of the Major Findings and Clinical ImplicationsYves Reznik, Michael Joubert
Annales D'Endocrinologie|April 20, 2023
EditorialYves Reznik, Luca Persani,
Diabetes, Obesity & Metabolism|April 12, 2023
Use of insulin pumps and closed-loop systems among people living with diabetes: A narrative review of clinical and cost-effectiveness to enable access to technology and meet the needs of payersJohan Jendle, Yves Reznik
Diabetes Technology & Therapeutics|September 6, 2014
Reductions in A1C with pump therapy in type 2 diabetes are independent of C-peptide and anti-glutamic acid decarboxylase antibody concentrationsYves Reznik, Suiying Huang,
The Lancet. Digital Health|December 18, 2020
Closed-loop insulin delivery: understanding when and how it is effectivePierre-Yves Benhamou, Yves Reznik
Pageof 14